Indonesia · Delayed Price · Currency is IDR PT Suparma Tbk Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 879.52 billion. The enterprise value is 1.66 trillion.
| Market Cap | 879.52B |
| Enterprise Value | 1.66T |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Suparma Tbk has 5.33 billion shares outstanding.
| Current Share Class | 5.33B |
| Shares Outstanding | 5.33B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.02% |
| Float | 776.64M |
Valuation Ratios
The trailing PE ratio is 9.77.
| PE Ratio | 9.77 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | 1.24 |
| P/OCF Ratio | 1.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.61, with an EV/FCF ratio of 2.33.
| EV / Earnings | 18.43 |
| EV / Sales | 0.59 |
| EV / EBITDA | 4.61 |
| EV / EBIT | 7.11 |
| EV / FCF | 2.33 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.96 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 2.52 |
| Debt / FCF | 1.27 |
| Interest Coverage | 5.27 |
Financial Efficiency
Return on equity (ROE) is 3.63% and return on invested capital (ROIC) is 5.51%.
| Return on Equity (ROE) | 3.63% |
| Return on Assets (ROA) | 3.94% |
| Return on Invested Capital (ROIC) | 5.51% |
| Return on Capital Employed (ROCE) | 7.51% |
| Weighted Average Cost of Capital (WACC) | 5.40% |
| Revenue Per Employee | 3.35B |
| Profits Per Employee | 107.22M |
| Employee Count | 840 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 2.04 |
Taxes
In the past 12 months, PT Suparma Tbk has paid 27.53 billion in taxes.
| Income Tax | 27.53B |
| Effective Tax Rate | 23.41% |
Stock Price Statistics
The stock price has increased by +2.52% in the last 52 weeks. The beta is 0.52, so PT Suparma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +2.52% |
| 50-Day Moving Average | 161.99 |
| 200-Day Moving Average | 177.68 |
| Relative Strength Index (RSI) | 50.30 |
| Average Volume (20 Days) | 668,320 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.81 trillion and earned 90.07 billion in profits. Earnings per share was 16.90.
| Revenue | 2.81T |
| Gross Profit | 466.81B |
| Operating Income | 233.47B |
| Pretax Income | 117.59B |
| Net Income | 90.07B |
| EBITDA | 353.69B |
| EBIT | 233.47B |
| Earnings Per Share (EPS) | 16.90 |
Balance Sheet
The company has 127.08 billion in cash and 907.54 billion in debt, with a net cash position of -780.46 billion or -146.42 per share.
| Cash & Cash Equivalents | 127.08B |
| Total Debt | 907.54B |
| Net Cash | -780.46B |
| Net Cash Per Share | -146.42 |
| Equity (Book Value) | 2.53T |
| Book Value Per Share | 473.95 |
| Working Capital | 768.04B |
Cash Flow
In the last 12 months, operating cash flow was 792.31 billion and capital expenditures -80.35 billion, giving a free cash flow of 711.96 billion.
| Operating Cash Flow | 792.31B |
| Capital Expenditures | -80.35B |
| Depreciation & Amortization | 120.22B |
| Net Borrowing | -730.25B |
| Free Cash Flow | 711.96B |
| FCF Per Share | 133.57 |
Margins
Gross margin is 16.58%, with operating and profit margins of 8.29% and 3.20%.
| Gross Margin | 16.58% |
| Operating Margin | 8.29% |
| Pretax Margin | 4.18% |
| Profit Margin | 3.20% |
| EBITDA Margin | 12.57% |
| EBIT Margin | 8.29% |
| FCF Margin | 25.29% |
Dividends & Yields
PT Suparma Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 10.24% |
| FCF Yield | 80.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 9, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
PT Suparma Tbk has an Altman Z-Score of 1.88 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 5 |